Interleukin 1α, interleukin 1β and interleukin 1 receptor gene polymorphisms in psoriatic arthritis

Rheumatology

Volumn 43, Issue 1, 2004, Pages 22-26

  Ravindran, J S ^b   Owen, P ^b   Lagan, A ^a   Lewis, J ^b   Korendowych, E ^b   Welsh, K ^a   McHugh, N J ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Cytokine gene; Interleukin 1; Psoriatic arthritis

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; RECEPTOR SUBTYPE; INTERLEUKIN 1;

ADULT; AGED; ARTICLE; CHROMOSOME 2Q; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; GENE LINKAGE DISEQUILIBRIUM; GENETICS; IMMUNOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; PSORIASIS;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC MARKERS; HOMOZYGOTE; HUMANS; INTERLEUKIN-1; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PSORIASIS; RECEPTORS, INTERLEUKIN-1;

EID: 0347724078     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg443     Document Type: Article

References (39)

1. Kay LJ, Parry-James JE, Walker DJ. The prevalence and impact of psoriasis and psoriatic arthritis in the primary care population in North East England. Arthritis Rheum 1999;42:S299.
2. Henseler T. The genetics of psoriasis. J Am Acad Dermatol 1997;37:S1-11.
3. McHugh NJ, Balakrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis. Rheumatology 2003;42:778-83.
4. Elder JT, Nair RP, Voorhees JJ. Epidemiology and the genetics of psoriasis. J Invest Dermatol 1994;102:24S-27S.
5. van Steensel MA, Steijlen PM. Genetics of psoriasis. Clin Dermatol 1997;15:669-75.
6. Nair RP, Stuart P, Henseler T et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 2000;66:1833-44.
7. Dawkins R, Leelayuwat C, Gaudieri S et al. Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev 1999;167:275-304.
8. Tiilikainen A, Lassus A, Karvonen J, Vartianen P, Julin M. Psoriasis and HLA-Cw6. Br J Dermatol 1980;102:179-84.
9. Asahina A, Akazaki S, Nakagawa H et al. Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris. J Invest Dermatol 1991;97:254-8.
10. Gladman DD, Cheung C, Ng CM, Wade JA. HLA-C locus alleles in patients with psoriatic arthritis (PsA). Hum Immunol 1999;60: 259-61.
11. Armstrong RD, Panayi GS, Welsh KI. Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis. Ann Rheum Dis 1983;42:142-6.
12. McHugh NJ, Laurent MR, Treadwell BL, Tweed JM, Dagger J. Psoriatic arthritis: clinical subgroups and histocompatibility antigens. Ann Rheum Dis 1987;46:184-8.
13. Samuelsson L, Enlund F, Torinsson A et al. A genome-wide search for genes predisposing to familial psoriasis by using a stratification approach. Hum Genet 1999;105:523-9.
14. Capon F, Novelli G, Semprini S et al. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol 1999;112:32-5.
15. Matthews D, Fry L, Powles A et al. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nature Genet 1996;14: 231-3.
16. Tomfohrde J, Silverman A, Barnes R et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994;264:1141-5.
17. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 2002;13:323-40.
18. Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 1995;270:13757-65.
19. van den Berg WB, Joosten LA, van de Loo FA. TNF alpha and IL-1 beta are separate targets in chronic arthritis. Clin Exp Rheumatol 1999;17:S105-S114.
20. Bresnihan B, Alvaro-Gracia JM, Cobby M et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998;41:2196-204.
21. Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 2000;43:1244-56.
22. Partsch G, Steiner G, Leeb BF, Dunky A, Bröll H, Smolen JS. Highly increased levels of tumor necrosis factor-a and other proinflammatory cytokines in psoriatic arthritis fluid. Br J Rheumatol 1997;24:518-23.
23. Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994;19:382-4.
24. Hulkkonen J, Laippala P, Hurme M. A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. Eur Cytokine Netw 2000;11:251-5.
25. Buchs N, Di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun 2001;2:222-8.
26. Kaijzel EL, van Dongen H, Bakker AM, Breedveld FC, Huizinga TW, Verweij CL. Relationship of polymorphisms of the interleukin-1 gene cluster to occurrence and severity of rheumatoid arthritis. Tissue Antigens 2002;59:122-6.
27. Tarlow JK, Cork MJ, Clay FE et al. Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis. Br J Dermatol 1997;136: 147-8.
28. van der PM, Crusius JB, Garcia-Gonzalez MA et al. Interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology 2002;41:1419-23.
29. Mansfield JC, Holden H, Tarlow JK et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994;106:637-42.
30. Gu J, Marker-Hermann E, Baeten D et al. A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. Rheumatology 2002;41:759-66.
31. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78.
32. Hunt PJ, Marshall SE, Weetman AP et al. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin Endocrinol 2001;55: 491-9.
33. Hutyrova B, Pantelidis P, Drabek J et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2002;165: 148-51.
34. Cox A, Camp NJ, Nicklin MJ, Di Giovine FS, Duff GW. An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet 1998;62:1180-8.
35. Reich K, Mossner R, Konig IR, Westphal G, Ziegler A, Neumann C. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1 beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Invest Dermatol 2002;118:155-63.
36. Bowcock AM, Shannon W, Du F et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 2001;10:1793-805.
37. Laval SH, Timms A, Edwards S et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918-26.
38. McGarry F, Neilly J, Anderson N, Sturrock R, Field M. A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology 2001;40:1359-64.
39. Vamvakopoulos J, Green C, Metcalfe S. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 2002;32:2988-96.